[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112012003092A2 - composições e métodos para implantação de tecido adiposo processado e produtos de tecido adiposo processados. - Google Patents

composições e métodos para implantação de tecido adiposo processado e produtos de tecido adiposo processados.

Info

Publication number
BR112012003092A2
BR112012003092A2 BR112012003092A BR112012003092A BR112012003092A2 BR 112012003092 A2 BR112012003092 A2 BR 112012003092A2 BR 112012003092 A BR112012003092 A BR 112012003092A BR 112012003092 A BR112012003092 A BR 112012003092A BR 112012003092 A2 BR112012003092 A2 BR 112012003092A2
Authority
BR
Brazil
Prior art keywords
adipose tissue
processed adipose
implanting
compositions
methods
Prior art date
Application number
BR112012003092A
Other languages
English (en)
Inventor
Iwen Wu
Jennifer H Elisseeff
Zayna Nahas
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of BR112012003092A2 publication Critical patent/BR112012003092A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Materials For Medical Uses (AREA)
BR112012003092A 2009-08-11 2010-08-11 composições e métodos para implantação de tecido adiposo processado e produtos de tecido adiposo processados. BR112012003092A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23291509P 2009-08-11 2009-08-11
PCT/US2010/045177 WO2011019822A2 (en) 2009-08-11 2010-08-11 Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products

Publications (1)

Publication Number Publication Date
BR112012003092A2 true BR112012003092A2 (pt) 2016-11-29

Family

ID=43586810

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012003092A BR112012003092A2 (pt) 2009-08-11 2010-08-11 composições e métodos para implantação de tecido adiposo processado e produtos de tecido adiposo processados.

Country Status (8)

Country Link
US (3) US20120189588A1 (pt)
EP (1) EP2464724A4 (pt)
JP (1) JP2013501586A (pt)
CN (1) CN102575229A (pt)
AU (1) AU2010282571B2 (pt)
BR (1) BR112012003092A2 (pt)
CA (1) CA2770490C (pt)
WO (1) WO2011019822A2 (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010033726A2 (en) 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Drug delivery composition comprising a self-assembled gelator
US9034386B2 (en) 2009-12-17 2015-05-19 Queen's University At Kingston Decellularized adipose tissue
WO2012002986A2 (en) * 2009-12-21 2012-01-05 The Regents Of The University Of California Decellularized and delipidized extracellular matrix and methods of use
EP3412279B1 (en) 2010-09-24 2021-02-17 The Brigham and Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
CN102114269B (zh) * 2011-02-22 2013-12-11 上海微创医疗器械（集团）有限公司 一种异氰基封端型防钙化人工生物瓣及其制备方法
WO2012166538A1 (en) * 2011-05-27 2012-12-06 Cormatrix Cardiovascular, Inc. Sterilized, acellular extracellular matrix compositions and methods of making thereof
EP3851131A1 (en) * 2011-05-31 2021-07-21 LifeCell Corporation Adipose tissue matrices
US9089523B2 (en) * 2011-07-28 2015-07-28 Lifecell Corporation Natural tissue scaffolds as tissue fillers
US8716363B2 (en) * 2011-09-28 2014-05-06 Globus Medical, Inc. Biodegradable putty compositions and implant devices, methods, and kits relating to the same
US20180126033A9 (en) 2012-03-14 2018-05-10 MAM Holdings of West Florida, L.L.C. Collagen compositions and uses for biomaterial implants
US10576037B2 (en) * 2012-03-14 2020-03-03 MAM Holdings of West Florida, L.L.C. Compositions comprising placental collagen for use in wound healing
CN102671242B (zh) * 2012-05-24 2014-04-23 东华大学 一种脱细胞心包材料的制备方法
CN103536967B (zh) * 2012-07-10 2016-04-13 上海微创医疗器械（集团）有限公司 一种制备细胞外基质支架材料的脱细胞方法
BR112015000547B1 (pt) 2012-07-13 2020-11-10 Lifecell Corporation método para tratar tecido
US20140056865A1 (en) * 2012-08-17 2014-02-27 Allosource Adipose composition systems and methods
WO2014052376A1 (en) * 2012-09-26 2014-04-03 Lifecell Corporation Processed adipose tissue
EP2712633B1 (de) * 2012-10-02 2015-04-29 Biotronik AG Bioprosthetische Komponenten für ein Implantat, insbesondere teilvernetzte biologische Herzklappen
AU2014296259B2 (en) 2013-07-30 2017-04-27 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
EP2832379B1 (de) * 2013-07-31 2015-07-22 Biotronik AG Verfahren zur Aufbereitung von biologischem Gewebe
US10537662B2 (en) 2013-07-31 2020-01-21 Biotronik Ag Method for preparing biological tissue
WO2015017772A1 (en) * 2013-08-01 2015-02-05 Parcell Laboratories, Llc Stem cell-based preparations and methods for dermal and connective tissue reconstruction and rejuvenation
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
CN104548207B (zh) * 2014-03-04 2017-11-07 四川大学华西医院 一种猪脂肪组织无细胞基质材料的制备方法
US20160008409A1 (en) * 2014-07-09 2016-01-14 Allosource Supercritical carbon dioxide tissue processing methods
AU2015301432B2 (en) 2014-08-15 2019-11-21 The Johns Hopkins University Composite material for tissue restoration
CA2974120A1 (en) * 2015-01-21 2016-07-28 Lifecell Corporation Tissue matrices with controlled porosity or mechanical properties
WO2016172365A1 (en) 2015-04-21 2016-10-27 Purdue Research Foundation Office Of Technology Commercialization Cell-collagen-silica composites and methods of making and using the same
JP6682385B2 (ja) * 2015-07-01 2020-04-15 花王株式会社 固形状組成物
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
EP3334835B1 (en) * 2015-08-11 2024-10-02 Acro Biomedical Company. Ltd. Preparation of high purity collagen particles and used thereof
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
GB2549110A (en) * 2016-04-05 2017-10-11 Northwick Park Inst For Medical Res Ltd Tissue scaffolds
US20190117782A1 (en) * 2016-04-05 2019-04-25 The Regents Of The University Of California Cellularized hydrogels and methods of using the same
EP3452094B1 (en) 2016-05-06 2021-11-17 The Brigham and Women's Hospital, Inc. Binary self assembled gels for controlled delivery of encapsulated agents to cartilage
ES2841427T3 (es) 2016-07-05 2021-07-08 Lifecell Corp Matrices de tejido que incorporan múltiples tipos de tejido
US9993578B1 (en) * 2017-01-12 2018-06-12 Lorstan Pharmaceutical, LLC Silicone oil-in-water composition useful as an injectable filler and as a scaffold for collagen growth
WO2018144991A1 (en) 2017-02-03 2018-08-09 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
WO2018200750A1 (en) 2017-04-25 2018-11-01 Purdue Research Foundation 3-dimensional (3d) tissue-engineered muscle for tissue restoration
WO2018208822A1 (en) * 2017-05-08 2018-11-15 Alivio Therapeutics, Inc. Formulation of nanostructured gels for increased agent loading and adhesion
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
CA3075099A1 (en) * 2017-10-18 2019-04-25 Lifecell Corporation Adipose tissue products and methods of production
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
US11826488B2 (en) 2017-10-19 2023-11-28 Lifecell Corporation Flowable acellular tissue matrix products and methods of production
US20210402061A1 (en) 2018-05-09 2021-12-30 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery
CA3099733A1 (en) 2018-05-09 2019-11-14 The Johns Hopkins University Nanofiber-hydrogel composites for enhanced soft tissue replacement and regeneration
AU2019357859A1 (en) 2018-10-11 2021-06-03 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release
KR102071415B1 (ko) * 2018-11-28 2020-01-30 주식회사 도프 초임계유체를 이용한 세포외기질 추출방법 및 이에 따라 제조된 조직 재생용 세포외기질 생체소재
CN109769799A (zh) * 2019-03-20 2019-05-21 江苏瑞思坦生物科技有限公司 一种人脂肪组织保存液及其制备方法
CN110215539B (zh) * 2019-05-28 2021-06-01 温州医科大学 一种用于胰岛细胞移植的凝胶基质及其制备方法
BR112021024043A2 (pt) 2019-05-30 2022-02-08 Lifecell Corp Implante mamário biológico
CN114286694B (zh) * 2019-08-27 2023-06-20 株式会社多富 动物脂肪源性细胞外基质及动物脂肪源性细胞外基质保存液
KR102333417B1 (ko) * 2019-08-27 2021-12-02 주식회사 도프 동물지방 유래 세포외기질 및 동물지방 유래 세포외기질 보존액
CN110612978A (zh) * 2019-09-26 2019-12-27 广东华夏健康生命科学有限公司 一种用于人月经血的保存液及其制备方法
US20230044236A1 (en) * 2019-12-17 2023-02-09 L&C Bio Co., Ltd. Medical Composition Comprising Adipose Tissue-Derived Extracellular Matrix And Method For Preparing Same
WO2021154845A1 (en) * 2020-01-27 2021-08-05 Geniphys, Llc Biologic filler for restoring and regenerating tissue
WO2021167920A1 (en) * 2020-02-18 2021-08-26 Apyx Medical Corporation Devices, systems and methods for sensing and discerning between fat and muscle tissue during medical procedures
CN111418579B (zh) * 2020-04-13 2021-05-18 广东华夏健康生命科学有限公司 一种脂肪组织的保存方法、脂肪组织的保存液及其制备方法
GB202106283D0 (en) * 2021-04-30 2021-06-16 Univ Nottingham Decellularized tissue hydrogels
CA3223186A1 (en) * 2021-07-13 2023-01-19 Alla Danilkovitch Adipose compositions and methods of use thereof
FR3135399A1 (fr) * 2022-03-30 2023-11-17 Laboratoires Vivacy émulsion comprenant un hydrogel et de la graisse ou un dérivé de graisse
WO2024107774A2 (en) * 2022-11-14 2024-05-23 Bio Creations Medical, Llc Biological tissue and method of manufacturing

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0008552A (pt) * 1999-03-10 2002-05-07 Univ Pittsburgh Células tronco e redes derivadas de tecido adiposo
US7008591B2 (en) * 2001-10-17 2006-03-07 Edwards Lifesciences Corporation Supercritical fluid extraction process for tissue preparation
US20040193274A1 (en) * 2003-03-28 2004-09-30 Trieu Hai H. Materials and methods for augmenting and/or repairing intervertebral discs
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
US7625581B2 (en) * 2003-12-19 2009-12-01 Ethicon, Inc. Tissue scaffolds for use in muscoloskeletal repairs
US20050209705A1 (en) * 2004-03-09 2005-09-22 Niederauer Gabriele G Implant scaffold combined with autologous or allogenic tissue
WO2006062989A1 (en) * 2004-12-07 2006-06-15 Bacterin International, Inc. Three-dimensional cell culsture system
US7550152B2 (en) * 2005-01-19 2009-06-23 National University Of Ireland, Galway Tissue graft scaffold made from cholecyst-derived extracellular matrix
WO2007025233A1 (en) * 2005-08-26 2007-03-01 Regents Of The University Of Minnesota Decellularization and recellularization of organs and tissues
KR20070095494A (ko) * 2005-09-28 2007-10-01 세원셀론텍(주) 지방 조직 수복용 반고형성 젤 조성물의 제조방법
US7829108B2 (en) * 2006-04-21 2010-11-09 Wake Forest University Health Sciences Structurally modified acellular tissue engineering scaffolds and methods of production
WO2008067085A2 (en) * 2006-10-23 2008-06-05 Cook Biotech Incorporated Processed ecm materials with enhanced component profiles
KR100771058B1 (ko) * 2007-05-18 2007-10-30 이희영 지질이 제거된 인체 부피 대체용 또는 세포 배양용 지지체및 그 제조방법
US9441200B2 (en) * 2008-02-11 2016-09-13 The Johns Hopkins University Compositions and methods for implantation of adipose tissue and adipose tissue products
US9034386B2 (en) * 2009-12-17 2015-05-19 Queen's University At Kingston Decellularized adipose tissue

Also Published As

Publication number Publication date
EP2464724A4 (en) 2013-11-20
CA2770490A1 (en) 2011-02-17
AU2010282571B2 (en) 2016-01-28
US20120189588A1 (en) 2012-07-26
US20180127719A1 (en) 2018-05-10
CN102575229A (zh) 2012-07-11
JP2013501586A (ja) 2013-01-17
WO2011019822A2 (en) 2011-02-17
US20220073881A1 (en) 2022-03-10
AU2010282571A1 (en) 2012-03-01
WO2011019822A3 (en) 2011-06-16
US11078461B2 (en) 2021-08-03
EP2464724A2 (en) 2012-06-20
CA2770490C (en) 2024-04-16

Similar Documents

Publication Publication Date Title
BR112012003092A2 (pt) composições e métodos para implantação de tecido adiposo processado e produtos de tecido adiposo processados.
BRPI0908087A2 (pt) Composições e métodos para implante de tecido adipose e produtos de tecido adiposo
BRPI1009920A2 (pt) composições bacterianas para profilaxina e tratamento de doença degenerativa.
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BR112012000882A2 (pt) Preparação cosmética capilar e método para aplicação.
BRPI1013829A2 (pt) composições e métodos para fermentação de biomassa
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BRPI1015336A2 (pt) composições para tratamento de tecidos que compreendem polímeros de organossiloxano
BRPI0807918A2 (pt) composições e método para preservação de tecido
BR112012031446A2 (pt) componentes e métodos para implantes
BRPI1010849A2 (pt) parafuso para ossos.
BRPI1012525A2 (pt) composições de nanopatículas isentas de príons e métodos para sua fabricação
BR112012000421A2 (pt) composições e métodos para intensificar a produção de um produto biológico.
FR2942627B1 (fr) Composition de graisse
MX344786B (es) Composiciones y metodos para tratar enfermedad de gaucher.
BRPI1008566A8 (pt) métodos e composições para o diagnóstico e tratamento de câncer
BR112013008957A2 (pt) composições e métodos para tratamento de doenças endócrinas, gastrointestinais ou autoimunes
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
BRPI1007600A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BRPI1008564A2 (pt) métodos e composições para o dignóstico e tratamento de câncer
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BRPI0911077A2 (pt) método para tratamento de biomassa
BRPI0909164A2 (pt) método e composições para o tratamento de câncer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL